[Exacerbation of ulcerative colitis and Crohn's disease following a change-over from salazosulfapyridine to 5-aminosalicylic acid].
作者信息
Feurle G E, Helmstädter V
出版信息
Dtsch Med Wochenschr. 1986 May 2;111(18):721-2.
PMID:2870908
Abstract
摘要
相似文献
1
[Exacerbation of ulcerative colitis and Crohn's disease following a change-over from salazosulfapyridine to 5-aminosalicylic acid].
Dtsch Med Wochenschr. 1986 May 2;111(18):721-2.
2
[Successful acute treatment of chronic inflammatory intestinal diseases with oral 5-aminosalicylic acid].
Dtsch Med Wochenschr. 1985 Mar 8;110(10):363-8. doi: 10.1055/s-2008-1068828.
3
[5-Aminosalicylic acid in ulcerative colitis and Crohn's disease (author's transl)].
Dtsch Med Wochenschr. 1982 Jul 23;107(29-30):1131-4. doi: 10.1055/s-2008-1070088.
4
Sulfasalazine and new analogues.
Am J Gastroenterol. 1986 Feb;81(2):141-4.
5
[Treatment of chronic inflammatory intestinal diseases with 5-aminosalicylic acid].
Internist (Berl). 1987 Jan;28(1):14-20.
6
Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease.
N Engl J Med. 1980 Dec 25;303(26):1499-502. doi: 10.1056/NEJM198012253032602.
7
[Aminosalicylates in chronic inflammatory intestinal diseases and rheumatoid arthritis].
Dtsch Med Wochenschr. 1992 Oct 16;117(42):1614-5.
8
Will there be a next generation of sulfasalazine?
Gastroenterology. 1982 Nov;83(5):1138-41.
9
[Salazosulfapyridine or 5-aminosalicylic acid].
Ned Tijdschr Geneeskd. 1987 May 30;131(22):931-4.
10
Drug insight: aminosalicylates for the treatment of IBD.
Nat Clin Pract Gastroenterol Hepatol. 2007 Mar;4(3):160-70. doi: 10.1038/ncpgasthep0696.
Zotero 插件